ATROPOS HEALTH INC — Form D
ATROPOS HEALTH INC of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2022-08-18. The offering totals $8.0M, of which $8.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2022-08-18
- Form: D
- Accession: 0001943427-22-000003
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $8.0M
- Amount sold: $8.0M
- Investors: 16
- Date of first sale: 2022-08-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-456271
Issuer
- Name: ATROPOS HEALTH INC
- CIK: 0001943427
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 169 MADISON AVENUE, NEW YORK, NY, 10016
- Phone: (646) 850-6610
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Mike Spadafore | Director | Austin, TX |
| Matthew Bettonville | Director | San Francisco, CA |
| Neil Sanghavi | Executive Officer | New York, NY |
| Nigam Shah | Director | New York, NY |
| Brigham Hyde | Director | New York, NY |
| Brigham Hyde | Executive Officer | New York, NY |
| Saurabh Gombar | Director | New York, NY |
| Saurabh Gombar | Executive Officer | New York, NY |
| James Breyer | Director | New York, NY |
Other filings by this issuer (2)
More